Topical immunosuprressives in ocular surface disorders

To evaluate the effect of topical immunosuppressives in ocular surface disorders. Cyclosporine A 0.05% eye drops was added to the regimen of the treatment of 30 eyes with different ocular surface disorders. Follow-up period was 6 months. Marked improvement in eyes with dry eye and resistant corneal ulcers at the end of the follow-up period. Topical immunosuppressives [cyclosporine A eye drops, 0.05%] has a curative effect on most of the ocular surface disorders